Saran Saund - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Saran Saund has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Saran Saund holds the role of CBO at Oncotelic Therapeutics, Inc. (OTLC). Saund has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.
| Role | CBO |
|---|---|
| Notability | 20/100 |
Board memberships
- Oncotelic Therapeutics, Inc.
Reported roles
- CBO
Awards & honors
- Serves as Chief Business Officer at Oncotelic Therapeutics, Inc. (as of 2026).
- Leads corporate development, strategic partnerships, and financing activities for the company (as inferred from CBO role).
Trading Pattern
InsiderAlpha's records for Saran Saund go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Saran Saund has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- CBO at Oncotelic Therapeutics, Inc. (OTLC) - 1 filing, 2026
Companies - Last 90 Days
- Oncotelic Therapeutics, Inc. (OTLC) - 1 filing, last 2026-07-14
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Saran Saund has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Vuong Trieu - $37K of OTLC open-market activity in the last 12 months
- Amit B. Shah - $1K of OTLC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Nicholas S. Schorsch
- Trygve Seglem
- Lawrence B. Seidman
- Thomas J. Shaw
- Silver Point Capital L.P.
- SilverBay Capital Management LLC
- Michael Simanovsky
- Bob R. Simpson
Frequently Asked Questions
Who is Saran Saund?
Saran Saund holds the role of CBO at Oncotelic Therapeutics, Inc. (OTLC). Saund has reported 1 insider filing with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Saran Saund submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Saran Saund's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Saran Saund profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.